Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Drägerwerk reports decline in EBIT in third quarter despite customs refunds
SDAX company Drägerwerk reported third-quarter earnings before interest and taxes of around €48 million, down from just under €57 million a year earlier; this figure includes customs refunds of €20.1 million. Revenue rose 2.1 percent to about €851 million, and order intake climbed 8.2 percent to €926 million. The annual forecast was confirmed. The share fell about 5 percent in after-hours trading to €109.60. » More on finanzen.net
Drägerwerk: €1,000 three years ago would be worth about €3,060 today
The Drägerwerk preferred share is slightly under pressure but, after a strong rally, remains markedly higher than three years ago. A hypothetical investment of €1,000 three years ago would, including reinvested dividends (€1.80 on 9 May 2024, €2.03 on 12 May 2025, €2.27 on 11 May 2026), have grown to around €3,063, equivalent to a total return of about 206%. Without dividends the value would be about €2,785, so most of the gain comes from the price increase. Taxes, order costs and rounding effects were not taken into account in the calculation. » More on deraktionaer.de
Drägerwerk may return to trend channel after strong rise
The Drägerwerk preferred share is trading near its yearly high and sits well above the medium-term upward trend channel; the RSI signals slight overbought conditions. Fundamentally, the company is supported by two recent price-target increases, and a further raise was discussed internally. However, after a year-to-date gain of almost 70%, the stock would be vulnerable to a market correction or profit-taking. Technically, the medium-term trend currently runs roughly around €102 on the upside and around €83 on the downside. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 847.3M | 8.63% |
| Gross profit | 395.21M | 15.57% |
| Net profit | 28.9M | 156.66% |
| EBITDA | 79.82M | 50.93% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.35B |
Number of shares | 17.76M |
52-week high/low | €95.80 - €36.60 |
Dividend yield | 2.93% |
Dividends TTM | €2.21 |
Beta | 1.22 |
P/E ratio | 11.16 |
PEG ratio | 0.15 |
P/B ratio | 1.15 |
P/S ratio | 0.54 |
Company profile
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
| Name | Drägerwerk |
| CEO | Stefan A. Drager |
| Headquarters | Lübeck,
sh Germany |
| Website | |
| Sector | Health Care |
| Industry | Health Care Technology |
| IPO | 06/24/2010 |
| Employees | 16,687 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
XETRA | DRW8.DE |
London Stock Exchange | 0MT8.L |
Pnk | DGWPF |
Frankfurt | DRW8.F |
Düsseldorf | DRW8.DU |
Hamburg | DRW8.HM |
London | 0MT8.L |
SIX | DRW8.SW |
München | DRW8.MU |